Veri-Cells™ CD138 Leukocytes

Cat #   427801 (10 tests)

Other Names  Syndecan-1, Control cells

Description  The reconstituted Veri-Cells™ CD138 Leukocytes can be used for immunofluorescent staining and multi-color flow cytometry assays. The cells can be used as controls for stability studies to avoid donor variability. Veri-Cells™ CD138 Leukocytes contain a mixture of both CD138-postive and CD138-negative cells. The CD19- CD45- CD138+ population co-expresses CD38, CD56, and CD269. In addition to these, the leukocyte population in this product has been verified to work with commonly tested cell markers such as CD3, CD4, CD8, CD19, CD20, CD56/16, CD14, CD25, CD69, HLA-DR, Granzyme B, Perforin, Foxp3, and Helios.
 This product contains human cells, a potentially biohazardous material. Blood used in preparation of these samples was tested and found to be negative, using FDA approved methods, for antibody and nucleic acid testing against Human Immunodeficiency virus (HIV), Hepatitis B and C viruses and HTLV (Human T-Lymphotropic virus I and II), surface antigen for Hepatitis B (HBsAg) virus and syphilis, and West Nile Virus. Biological tests are not 100% accurate. Use standard precautions when handling and treat as if the product is capable of transmitting diseases. When handling or disposing, follow precautions described in CDC and FDA recommendations and OSHA Bloodborne Pathogen guidelines.

Kit Contents 

Cat. No. 427801

2 vials of lyophilized Veri-Cells™ CD138 Leukocytes (≥ 1 x 106 cells per vial)

1 vial containing 0.7 mL of Veri-Cells™ Buffer B


Are most appropriate when you need reference/control cells for longitudinal, multi-center studies.


Reference laboratories, clinical research organizations, and multi-center clinical trials, among other institutions, need reliable controls to monitor assay performance and variability for longitudinal studies. Veri-Cells™ is our line of lyophilized control cell products, which can be used to help monitor data quality and aid in reproducibility in multi-center and longitudinal studies. 

Veri-Cells™ feature:

  • Exceptional long term stability
  • Scatter profile similar to fresh samples
  • Validation for the detection of over 150 markers


Veri-Cells™ CD138 Leukocytes
Veri-Cells™ Heavy Metal (Ta) PBMC

Veri-Cells™ Activated (Cytokine) PBMC

Veri-Cells™ Activated (Surface)

Veri-Cells™ Phospho PBMC (MAPK/ERK Pathway)

Veri-Cells™ CD34 PBMC

Veri-Cells™ Leukocytes

Veri-Cells™ CD4-Low PBMC

Veri-Cells™ PBMC

Veri-Cells™ CD138 Leukocytes

 Veri-Cells™ CD138 Leukocytescontain a mixture of human CD138+ cells and other leukocytes and can be used as controls to verify the expression of CD138, CD38, CD56 and CD269. In addition, Veri-Cells™ CD138 Leukocytes have been verified for expression of common markers, including CD3, CD4, CD8, CD19, CD20, CD56/16, CD14, CD25, CD69, HLA-DR, Granzyme B, Perforin, FOXP3, and Helios.

Veri-Cells™ CD138 Leukocytes were stained with anti-human CD45 (clone 2D1) PE, anti-human CD19 (clone SJ25C1) APC, anti-human CD38 (clone HIT2) FITC, and anti-human CD138 (clone MI15) Brilliant Violet 421™. CD45- and CD19- negative cells (left) were analyzed for CD138 and CD38 expression (right). Gates for the CD38 vs CD138 plot were set based on corresponding isotype controls.


Veri-Cells™ CD138 Leukocytes were stained with Human TBNK 6 Color Cocktail (Cat. No. 391503). CD45+ CD3+ and CD45+ CD3- cells (top right) were gated on lymphocytes (top left) and analyzed for lineage marker expression (bottom left/right).